Effects of Antioxidant Sugar vs Granulated Sugar on Metabolic Outcomes in Healthy and Cardio Metabolic Subjects

NCT04737044 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-02-08

No results posted yet for this study

Summary

Study 1: To investigate the effects of antioxidant-rich sugar as alternative compared to granulated sugar on gene expression and other metabolic parameters in healthy subjects.

The hypotheses is antioxidant-rich sugar have positive effects on reducing inflammatory cytokines, oxidative stress biomarkers and other metabolic parameters in intervention group compared to control group.

Study 2: To evaluate the effectiveness of a nutrition education module in modifying sugar consumption and other CMR-related outcomes in individuals with cardiometabolic risk.

The hypotheses is the nutrition education module significantly improves the sugar consumption and other CMR-related outcomes in the intervention groups compared to the control group

Conditions

  • Gene Expression
  • Cardiometabolic Risk
  • Metabolic Syndrome

Interventions

OTHER

Study 1: MRBS

MRBS as added sugar based on their habitual diet

OTHER

Study 2: White sugar & education module

White sugar for daily usage (\<10% daily energy intake)

OTHER

Study 2: MRBS & education module

MRBS for daily usage (\<10% daily energy intake)

Sponsors & Collaborators

  • Central Sugars Refinery Sdn Bhd, Malaysia

    collaborator UNKNOWN
  • Universiti Putra Malaysia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2022-06-01
Completion
2022-07-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737044 on ClinicalTrials.gov